MX2020006741A - Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar. - Google Patents
Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar.Info
- Publication number
- MX2020006741A MX2020006741A MX2020006741A MX2020006741A MX2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A
- Authority
- MX
- Mexico
- Prior art keywords
- nitric oxide
- pulmonary hypertension
- oxygen
- treatment
- inhaled nitric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0666—Nasal cannulas or tubing
- A61M16/0672—Nasal cannula assemblies for oxygen therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M16/101—Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen en la presente métodos para el uso de óxido nítrico inhalado para el tratamiento de la hipertensión pulmonar, la mejora de la capacidad de ejercicio y/o la reducción de la de saturación de oxígeno en un paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762611316P | 2017-12-28 | 2017-12-28 | |
PCT/US2018/067793 WO2019133776A1 (en) | 2017-12-28 | 2018-12-28 | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020006741A true MX2020006741A (es) | 2020-11-24 |
Family
ID=67068194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020006741A MX2020006741A (es) | 2017-12-28 | 2018-12-28 | Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20200360425A1 (es) |
EP (1) | EP3731913A4 (es) |
JP (1) | JP2021509108A (es) |
KR (1) | KR20200127157A (es) |
CN (1) | CN111867664A (es) |
AU (1) | AU2018394928A1 (es) |
BR (1) | BR112020012964A2 (es) |
CA (1) | CA3087195A1 (es) |
EA (1) | EA202091286A1 (es) |
IL (1) | IL275678A (es) |
MX (1) | MX2020006741A (es) |
PH (1) | PH12020550978A1 (es) |
SG (1) | SG11202005974YA (es) |
TW (1) | TW201929841A (es) |
WO (1) | WO2019133776A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
KR20220137155A (ko) | 2017-02-27 | 2022-10-11 | 써드 폴, 아이엔씨. | 산화질소의 이동식 생성을 위한 시스템 및 방법 |
CN110573454B (zh) | 2017-02-27 | 2021-08-20 | 第三极股份有限公司 | 生成一氧化氮的系统和方法 |
TW202021637A (zh) * | 2018-08-10 | 2020-06-16 | 美商貝勒羅豐治療公司 | 吸入性一氧化氮(iNO)用於改善嚴重低血氧症之用途 |
WO2020232397A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Electrodes for nitric oxide generation |
WO2020232419A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
EP4069069A4 (en) | 2020-01-11 | 2024-07-03 | Third Pole Inc | SYSTEMS AND METHODS FOR GENERATING NITRIC OXIDE WITH HUMIDITY CONTROL |
US20230201497A1 (en) * | 2020-05-29 | 2023-06-29 | Bellerophon Therapeutics | Method for pulsatile delivery of a gaseous drug |
US20210395905A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
US11975139B2 (en) | 2021-09-23 | 2024-05-07 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007333115B2 (en) * | 2006-12-12 | 2013-01-10 | Gilead Sciences, Inc. | Composition for treating a pulmonary hypertension |
WO2015148169A1 (en) * | 2014-03-28 | 2015-10-01 | Shape Medical Systems, Inc. | Pattern recognition system for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea |
BR112018011803A2 (pt) * | 2015-12-11 | 2018-12-04 | Vero Biotech LLC | método e mecanismo para a administração de gases incluindo óxido nítrico |
US20170182088A1 (en) * | 2015-12-28 | 2017-06-29 | Geno Llc | Method and apparatus for administering nitric oxide with supplemental drugs |
EP3413899A4 (en) * | 2016-02-12 | 2019-10-02 | Mallinckrodt Hospital Products IP Limited | USE AND MONITORING OF INHALED STAIN OXIDE WITH LEFT-VENTRICULAR SUPPORT DEVICES |
-
2018
- 2018-12-28 SG SG11202005974YA patent/SG11202005974YA/en unknown
- 2018-12-28 MX MX2020006741A patent/MX2020006741A/es unknown
- 2018-12-28 US US16/961,886 patent/US20200360425A1/en active Pending
- 2018-12-28 TW TW107147696A patent/TW201929841A/zh unknown
- 2018-12-28 CA CA3087195A patent/CA3087195A1/en active Pending
- 2018-12-28 EP EP18894329.4A patent/EP3731913A4/en active Pending
- 2018-12-28 BR BR112020012964-0A patent/BR112020012964A2/pt unknown
- 2018-12-28 WO PCT/US2018/067793 patent/WO2019133776A1/en unknown
- 2018-12-28 AU AU2018394928A patent/AU2018394928A1/en active Pending
- 2018-12-28 KR KR1020207021817A patent/KR20200127157A/ko not_active Application Discontinuation
- 2018-12-28 EA EA202091286A patent/EA202091286A1/ru unknown
- 2018-12-28 JP JP2020535026A patent/JP2021509108A/ja active Pending
- 2018-12-28 CN CN201880083635.9A patent/CN111867664A/zh active Pending
-
2020
- 2020-06-24 PH PH12020550978A patent/PH12020550978A1/en unknown
- 2020-06-25 IL IL275678A patent/IL275678A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2018394928A1 (en) | 2020-07-02 |
CN111867664A (zh) | 2020-10-30 |
CA3087195A1 (en) | 2019-07-04 |
JP2021509108A (ja) | 2021-03-18 |
PH12020550978A1 (en) | 2021-04-19 |
BR112020012964A2 (pt) | 2020-12-01 |
IL275678A (en) | 2020-08-31 |
WO2019133776A1 (en) | 2019-07-04 |
EA202091286A1 (ru) | 2020-11-05 |
US20200360425A1 (en) | 2020-11-19 |
EP3731913A1 (en) | 2020-11-04 |
KR20200127157A (ko) | 2020-11-10 |
SG11202005974YA (en) | 2020-07-29 |
EP3731913A4 (en) | 2021-09-01 |
TW201929841A (zh) | 2019-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020550978A1 (en) | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension | |
PH12020500197A1 (en) | Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease | |
PH12019501575A1 (en) | ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF | |
PH12020550979A1 (en) | Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension | |
MX2023000051A (es) | Metodos de acondicionamiento de pacientes para tratamiento con linfocitos t. | |
PH12017502103A1 (en) | Methods and kits for treating depression | |
MX2016005532A (es) | Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades. | |
MX2017011834A (es) | Macrociclos peptidomimeticos y usos de los mismos. | |
SG10201902594QA (en) | Peptidomimetic macrocycles and uses thereof | |
MX2021008007A (es) | Uso del oxido nitrico inhalado (ino) para mejorar los niveles de actividad en pacientes con afecciones relacionadas con el pulmon. | |
MX2021008418A (es) | Terapias de farmaco de combinacion de inhibidores de fosfodiesterasa tipo 5 (pde-5) y oxido nitrico inhalado. | |
PH12017501300A1 (en) | Novel iodophor composition and methods of use | |
MX2018010223A (es) | Terapia combinada para tratamiento de cancer de ovario. | |
PH12017500392A1 (en) | Medical treatments based on anamorelin | |
MX2015011905A (es) | Uso de levocetirizina y montelukast en el tratamiento de la vasculitis. | |
MX2021004755A (es) | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria. | |
MX2022014034A (es) | Métodos para tratar covid-19 con el uso de bardoxolona metilo o análogos de esta. | |
MX2021004207A (es) | Uso de reboxetina para el tratamiento de narcolepsia. | |
MX2020011738A (es) | Uso de calcifediol en pacientes de cirugia bariatrica. | |
EP4268899A3 (en) | Ferritin nanoparticles comprising a chemotherapeutic agent | |
EA202090151A1 (ru) | Применение вдыхаемого оксида азота (ii) для лечения легочной гипертензии, связанной с заболеванием легких | |
MX2018012587A (es) | (+)-azasetron para uso en el tratamiento de trastornos del oido. | |
TR201914615A2 (tr) | Fistül ve hemoroid tedavisinde kullanılmak üzere karboksiterapi kullanımı. | |
ZA202210311B (en) | Coronavirus therapeutics and treatment methods | |
UA87586U (uk) | Спосіб лікування гострої респіраторної вірусної інфекції у вагітних |